Provided by Tiger Fintech (Singapore) Pte. Ltd.

Incyte

68.77
+1.532.28%
Post-market: 68.770.00000.00%16:59 EDT
Volume:1.72M
Turnover:118.21M
Market Cap:13.31B
PE:708.79
High:68.98
Open:67.78
Low:67.62
Close:67.24
Loading ...

Incyte Reports Inducement Grants Under Nasdaq Listing Rule

Reuters
·
12 hours ago

Incyte Announces Inducement Grants with 16,550 RSUs to New Employees Under 2024 Incentive Plan

Reuters
·
12 hours ago

Healthcare companies are hiring. Is it time to look for growth stocks in this beaten-down sector?

Dow Jones
·
13 hours ago

Incyte Corporation's EVP & General Counsel Sheila A. Denton Reports Disposal of Common Shares

Reuters
·
Yesterday

Incyte’s Promising Drug Pipeline and INCA33989’s Strong Performance Drive Buy Rating

TIPRANKS
·
05 Jun

Evercore ISI Reaffirms Their Hold Rating on Incyte (INCY)

TIPRANKS
·
05 Jun

Incyte’s Mixed Clinical Trial Results and Uncertainties Lead to Hold Rating

TIPRANKS
·
04 Jun

Incyte’s CAO Makes a Significant Stock Sale!

TIPRANKS
·
04 Jun

Incyte (INCY) Gets a Hold from J.P. Morgan

TIPRANKS
·
04 Jun

Incyte Corp. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
04 Jun

Principal Accounting Officer Tray Thomas Reports Disposal of Common Shares of Incyte Corporation

Reuters
·
04 Jun

BMO Capital Reaffirms Their Sell Rating on Incyte (INCY)

TIPRANKS
·
04 Jun

Incyte’s Promising Clinical Trial Results and Favorable Safety Profile Drive Buy Rating with 34.7% Upside Potential

TIPRANKS
·
04 Jun

Citi says Incyte data show INCA33989 activity on intended target

TIPRANKS
·
04 Jun

BUZZ-Incyte rises after co teases new research data for possible blood cancer treatment

Reuters
·
04 Jun

Incyte Is Maintained at Neutral by UBS

Dow Jones
·
04 Jun

RBC says EHA late-breaking abstract shows Incyte may have drug in mCALR mAb

TIPRANKS
·
03 Jun

Incyte Corporation Unveils Promising Late-Breaking Data for Novel mutCALR-Directed Monoclonal Antibody at EHA 2025 Congress

Reuters
·
03 Jun

Incyte Announces Multiple Presentations, Including New Late-Breaking Data for Its Mutcalr-Directed Monoclonal Antibody (Inca033989), Accepted for Presentation at Eha 2025

THOMSON REUTERS
·
03 Jun

20 Stocks Primed for Rapid Growth While Trading at Half of Nvidia’s Valuation

Dow Jones
·
03 Jun